Pfizer’s Bextra Banned In Singapore. Singapore has suspended the sales of ‘Bextra’, an anti-inflammatory drug produced by the global pharmaceutical manufacturer Pfizer.
Study shows that taking ‘Bextra’ may pose risk to patients’ cardiovascular safety or incur rare but serious skin reactions, which have led to similar bans on the drug in the United States, the European Union and Canada.
Serious Skin Reactions Had Been Reported
The Health Sciences Authority (HSA) of Singapore confirmed that no local case of serious skin reactions had been reported, but it advised patients taking the drug to consult their doctors for alternative treatments.
Commonly used to treat osteoarthritis or rheumatoid arthritis, ‘Bextra’ has entered Singapore market since May 2003 to deal with acute pain, the report said. Enditem
Need Legal Help Regarding Pfizer’s Bextra?
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Our attorneys for Bextra lawsuit are here to help you when you need it the most.